
JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact
11/12/2025
0:00
38:19
See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.
Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
Otros episodios de "Keeping Current CME"



No te pierdas ningún episodio de “Keeping Current CME”. Síguelo en la aplicación gratuita de GetPodcast.







